Prognostic Value of Liver Function and Tumor Burden Scores in Patients with HCC After Transarterial Radioembolization – Retrospective Single Center Analysis
Aaron Schindler, Anne Beeskow, Janett Fischer, Sebastian Ebel, Timm Denecke, Daniel Seehofer, Thomas Lincke, Osama Sabri, Thomas Berg, Florian van Bömmel · 2026
Read Prognostic Value of Liver Function and Tumor Burden Scores in Patients with HCC After Transarterial Radioembolization – Retrospective Single Center Analysis by Aaron Schindler, Anne Beeskow, Janett Fischer, Sebastian Ebel, Timm Denecke, Daniel Seehofer, Thomas Lincke, Osama Sabri, Thomas Berg, Florian van Bömmel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473070.txt.
Description
A peer-reviewed research article from Europe PMC (2026). BackgroundTransarterial radioembolization (TARE) is an established locoregional therapy for advanced hepatocellular carcinoma (HCC). Prognosis depends on both tumor progression and hepatic function. Despite multiple scoring systems, predicting therapeutic benefit remains challenging.Materials and MethodsThis study evaluated the prognostic performance of established scores (BCLC, HAP, CLIP, OKUDA, ALBI, MELD, and Child-Pugh) for survival after TARE in 86 patients with HCC and liver cirrhosis.
Catalog record
| CREATOR | Aaron Schindler, Anne Beeskow, Janett Fischer, Sebastian Ebel, Timm Denecke, Daniel Seehofer, Thomas Lincke, Osama Sabri, Thomas Berg, Florian van Bömmel |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |